UnknownNot Applicable

Effectiveness of T2* MRI in Cervical Spondylotic Myelopathy

200 participantsStarted 2010-01

Plain-language summary

Utilization of T2\* MRI in predicting prognosis in patients with cervical spondylotic myelopathy (CSM)

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosed with CSM and operated on by one senior orthopedist * available preoperative MRI results * high-quality image data with no motion artifacts * available preoperative and long-term follow-up (≥1 years) mJOA score Exclusion Criteria: * prior head or neck surgery * a history of notable additional diseases (spinal cord tumor, multiple sclerosis, syringomyelia, spinal cord injury, or motor neuron disease).

What they're measuring

Improvement of neurologic function

Timeframe: at follow-up time (≥1 years)

Trial details

NCT IDNCT04955041

SponsorPeking University Third Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-07

View on ClinicalTrials.gov More Cervical Spondylotic Myelopathy trials